Bio View (Israel) Today

BIOV Stock  ILS 29.70  0.50  1.71%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Bio View is trading at 29.70 as of the 28th of March 2024, a 1.71 percent up since the beginning of the trading day. The stock's open price was 29.2. Bio View has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Bio View are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. The company has 13.75 M outstanding shares. More on Bio View
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bio Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio View's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio View or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Co-CEO, DirectorYuval Harari
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Bio View (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 35 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio View's market, we take the total number of its shares issued and multiply it by Bio View's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio-View operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.75 M outstanding shares. Bio View has accumulated about 17.67 M in cash with 3.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check Bio View Probability Of Bankruptcy
Ownership Allocation
Bio-View retains a total of 13.75 Million outstanding shares. Bio View retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Bio Ownership Details

Bio Stock Price Odds Analysis

What are Bio View's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Bio View jumping above the current price in 90 days from now is about 69.0%. The Bio View probability density function shows the probability of Bio View stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.6602 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bio View will likely underperform. Additionally, bio View has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 29.7HorizonTargetOdds Above 29.7
30.95%90 days
 29.70 
69.00%
Based on a normal probability distribution, the odds of Bio View to move above the current price in 90 days from now is about 69.0 (This Bio View probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .

Bio-View Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bio View market risk premium is the additional return an investor will receive from holding Bio View long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio View. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bio View's alpha and beta are two of the key measurements used to evaluate Bio View's performance over the market, the standard measures of volatility play an important role as well.

Bio Stock Against Markets

Picking the right benchmark for Bio View stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bio View stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bio View is critical whether you are bullish or bearish towards Bio View at a given time. Please also check how Bio View's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bio View without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Bio View Corporate Directors

Bio View corporate directors refer to members of a Bio View board of directors. The board of directors generally takes responsibility for the Bio View's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bio View's board members must vote for the resolution. The Bio View board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy Bio Stock?

Before investing in Bio View, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bio View. To buy Bio View stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bio View. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Bio View stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Bio View stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Bio View stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bio View, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Bio View?

The danger of trading Bio View is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bio View is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bio View. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bio-View is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.